Purple Cross Patient Care Association, is a Not-for-Profit Association operating for residents of the State of Washington.
Our goal is to help bring about healing and understanding throughout the community through research, while promoting the benifits of injesting pure non-heat-activated raw cannabis oil, mixed with pure cold pressed Hempseed oil.
First, the Cannabis Oil that is extracted using 'ACS Reagent Grade Acetone', is as pure as it gets. That same Cannabis oil is the highest concentration of Essential Oils of anything on the Planet.
Essential, because we don't make them naturally but our bodies need them.
Second, the coldpressed Hempseed Oil, is the highest concentration of Essential Fatty Acids of anything on the plant, and has ALL of the Omegas, 3 ALA, SDA; 6 LA, GLA; and 9 oleic acid represented in great amounts.
After they have been mixed together, and that oil is then injested by any Mammal on the Planet, it turns naturally into Endocannabinoids.
Beyond Marijuana: Endocannabinoids and Therapies
For years, cannabis was used medicinally without a clear understanding of how and where it acted in the brain and body. Now, several decades of research has provided a better understanding of how cannabis works, allowing scientists to harness the therapeutic effects of its main mind-altering ingredient and the proteins on which it acts. The body makes its own versions of this ingredient, called endocannabinoids, which help regulate almost all brain and body processes. Understanding of endocannabinoids already is used to treat obesity and symptoms of multiple sclerosis. Future research looks to capture the power of endocannabinoids to help treat other diseases and conditions, from nicotine addiction and alcoholism to epilepsy, Parkinson's disease, pain, anxiety, and depression.
Cannabis has been used medicinally for centuries, but it wasn't until recently that cannabis research led to safer and more effective treatment possibilities. In the 1990s, scientists found and copied the receptors-proteins located on the surface of brain and body cells-responsible for many actions of tetrahydrocannabinol (THC), the main mind-altering ingredient of cannabis. This discovery allowed scientists to harness the therapeutic effects of THC and its receptors. Now, several decades of research has led to improved treatments for obesity, symptoms of multiple sclerosis, and, potentially, Parkinson's disease, epilepsy, anxiety, and depression, to name a few.
The body makes its own versions of THC, dubbed endocannabinoids, which work by binding to the same specific receptors as THC. Endocannabinoids travel in the opposite direction of most brain signals. In this way, they play a part in regulating almost all brain and body processes, making endocannabinoids prime targets for treating many diseases and conditions.
A significant advance came when scientists discovered ways to modify endocannabinoid activity indirectly, thus avoiding the potential for abuse and the perception, mood, and behavior changes associated with THC. Most current methods either decrease endocannabinoid activity by blocking the receptors on which they act, or enhance the action of endocannabinoids by inhibiting their breakdown, usually by blocking the enzymes that inactivate them.
Recent research has revealed:
• Several endocannabinoids in the brain and body, with two main types implicated in the treatment of many diseases and conditions, such as obesity, pain, anxiety, and Parkinson's disease.
• Two endocannabinoid receptors: one found in the brain and some body tissues that is involved in conditions like obesity and anxiety, and another located mainly in the body periphery, which is involved in pain and inflammatory conditions.
